chenodeoxycholic acid has been researched along with indomethacin in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (20.00) | 18.7374 |
| 1990's | 4 (26.67) | 18.2507 |
| 2000's | 4 (26.67) | 29.6817 |
| 2010's | 4 (26.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Strassburg, CP; Tukey, RH | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Del Soldato, P; Meli, A | 1 |
| Hata, Y; Hiraishi, H; Mutoh, H; Ota, S; Sugimoto, T; Terano, A; Tsukahara, H | 1 |
| Erickson, RA | 2 |
| Marci, M; Palleschi, M | 1 |
| Hata, Y; Ivey, KJ; Kawabe, T; Ota, S; Razandi, M; Terano, A | 1 |
| Moriwaki, H; Muto, Y; Nishigaki, Y; Ohnishi, H | 1 |
| Fujimoto, Y; Iida, T; Yasukawa, K | 1 |
3 review(s) available for chenodeoxycholic acid and indomethacin
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Current studies of the clinical aspects and drug therapy of biliary calculosis in the elderly].
Topics: Age Factors; Aged; Anti-Bacterial Agents; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholelithiasis; Humans; Indomethacin; Ursodeoxycholic Acid | 1981 |
12 other study(ies) available for chenodeoxycholic acid and indomethacin
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Further investigations of indomethacin and intestinal ulcers in the rat.
Topics: Animals; Bile; Chenodeoxycholic Acid; Eating; Female; Indomethacin; Male; Peptic Ulcer; Rats; Stomach; Time Factors | 1978 |
Protective effect of tauroursodeoxycholate against chenodeoxycholate-induced damage to cultured rabbit gastric cells.
Topics: Animals; Bile Acids and Salts; Calcium; Cells, Cultured; Chenodeoxycholic Acid; Dinoprostone; Dose-Response Relationship, Drug; Female; Free Radicals; Gastric Mucosa; Indomethacin; Isomerism; Male; Rabbits; Taurochenodeoxycholic Acid; Verapamil | 1991 |
Intraperitoneal injection induces prostaglandin-mediated protection from bile acid intestinal mucosal injury in rats in vivo.
Topics: Animals; Chenodeoxycholic Acid; Epithelium; Indomethacin; Injections, Intraperitoneal; Intestinal Mucosa; Intestine, Small; Male; Perfusion; Prostaglandins; Rats; Rats, Inbred Strains | 1990 |
Effect of 16,16-dimethyl PGE2 and indomethacin on bile acid-induced intestinal injury and restitution in rats.
Topics: 16,16-Dimethylprostaglandin E2; Animals; Body Water; Chenodeoxycholic Acid; Indomethacin; Intestinal Absorption; Intestinal Mucosa; Male; Mannitol; Prostaglandins E, Synthetic; Rats; Rats, Inbred Strains | 1988 |
Bile salts stimulate mucous glycoprotein secretion from cultured rabbit gastric mucosal cells.
Topics: Animals; Bile Acids and Salts; Calcium; Cells, Cultured; Chenodeoxycholic Acid; Deoxycholic Acid; Dinoprostone; Dose-Response Relationship, Drug; Gastric Mucosa; Glycodeoxycholic Acid; Glycoproteins; Indomethacin; Male; Mucins; Rabbits; Radioimmunoassay; Taurodeoxycholic Acid; Time Factors | 1994 |
Ursodeoxycholic acid corrects defective natural killer activity by inhibiting prostaglandin E2 production in primary biliary cirrhosis.
Topics: Adult; Aged; Cells, Cultured; Chenodeoxycholic Acid; Cholic Acid; Cholic Acids; Chronic Disease; Deoxycholic Acid; Dinoprostone; Female; Hepatitis C; Humans; Indomethacin; Killer Cells, Natural; Liver Cirrhosis, Biliary; Liver Diseases; Male; Middle Aged; Ursodeoxycholic Acid | 1996 |
Relative inhibitory activity of bile acids against 12-O-tetradecanoylphorbol-13-acetate-induced inflammation, and chenodeoxycholic acid inhibition of tumour promotion in mouse skin two-stage carcinogenesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anti-Inflammatory Agents; Anticarcinogenic Agents; Bile Acids and Salts; Carcinogens; Chenodeoxycholic Acid; Disease Models, Animal; Edema; Female; Indomethacin; Inflammation; Inhibitory Concentration 50; Mice; Mice, Inbred ICR; Neoplasms, Experimental; Skin Neoplasms; Structure-Activity Relationship; Tetradecanoylphorbol Acetate | 2009 |